In the article titled “Management of Morgellons Disease With Low-Dose Trifluoperazine,”1 an error occurred in the last paragraph of the Results section concerning the number of patients who achieved at least partial responses and baseline function with median dosages of the study treatment. The sentence now reads, “Among patients with median dosages of 2 mg/d, 10 (71%) achieved at least partial responses and 7 (50%) achieved baseline function…”. The article was corrected online.
Reference
- 1.Yan BY, Jorizzo JL. Management of Morgellons disease with low-dose trifluoperazine [published online January 10, 2018]. JAMA Dermatol. doi: 10.1001/jamadermatol.2017.5175 [DOI] [PMC free article] [PubMed] [Google Scholar]
